Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation: Lessons From a 5-Year Follow-Up

By F. Ouyang, R. Tilz, J. Chun, B. Schmidt, E. Wissner, T. Zerm, K. Neven, B. Köktürk, M. Konstantinidou, A. Metzner and 2 more. Circulation, 2010

691 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/fed19d9f506acaf62152b1a49ddab288218bda13

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. M. Ezekowitz
2. Stanley Nattel
3. Gerhard Hindricks

Citations in the corpus

• Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. (2014, background): “More concerning is that, despite further ablation and a period without arrhythmia, progressive attrition in success is observed with time (13,14,18).”
• Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis (2013, neutral): “Mechanisms of Recurrence Mechanisms of recurrence were reported in 5 studies.(16,17,19,21,22) In these 5 studies, 3 of which reported data exclusively from PAF patients, PV reconnection was noted in 417 of 423 patients who underwent repeat ablation; the rate of ≥1 PV reconnection was 97.”
• 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, background): “Multiple studies of long-term follow-up data (more than 5 years) have demonstrated that the longer the follow-up postablation, the higher the recurrence rate.(266,267,268) The predominant mechanism of very late recurrence includes PV reconnection, the development of non-PV triggers, and development ”
• 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, background): “Regeneration of those axons may contribute to late recurrence of AF after PVI [72, 73].”